🚨Merck ditching its £1bn UK expansion must be a wake-up call for the Government.

💡While the US backs innovation, the UK is falling behind. We need a bold, cross-party life sciences strategy to attract investment and keep the UK at the forefront of global research.

A new study from @lshtm.bsky.social highlights the disparity of survival rates between cancer types, including less survivable cancers. “The National Cancer Plan must… make meaningful strides in improving outcomes for all patients.” Read our full statement here ➡️ shorturl.at/JFlFb

@drscottarthurmp.bsky.social

Rare Cancers Bill has passed its Third Reading!

Despite their being some jeopardy earlier in the week, the whole rare disease community unified and acted to ensure that it didn’t fall.

This Bill has the chance to be transformational for rare cancer patients.

The Taskforce supports the Rare Cancers Bill. The Bill reaches its 3rd reading in Parliament tomorrow, Friday 12 July and we need at least 40 MPs in Westminster to ensure it progresses.
👉 We are calling on all MPs to attend and support the Bill.

The Rare Cancers Bill has had months of cross party support but is in danger of not passing due to an amendment being tabled.

This is a chance to see real change for the rare cancer community, so please write to your MP and encourage them attend the Third Reading on Friday!

shorturl.at/kteH8

A real pleasure to introduce @drscottarthurmp.bsky.social at the @cancer52org.bsky.social meeting this week and hear his motivation and hopesfor leading the Rare Cancers Bill. A chance for real change.

Proud to have been a part of this.

Did you know that according to data, brain tumour trials have the lowest recruitment levels of any cancer type?

Today we have launched our latest policy report exploring barriers to research participation and how these challenges can be overcome:
www.thebraintumourcharity.org/news/policy-...

An ultra-rapid method of genetically diagnosing brain tumours has been developed, cutting the classification time from 6-8 weeks, to as little as two hours. This could remove the uncertainty that those face waiting weeks for their diagnosis and prognosis. Read more: bit.ly/3YU9Qbb

Our new report reveals a third of respondents didn’t know they could directly request brain scans for suspected brain tumours. Even among those who did, many weren’t clear on how to use this guidance. 🧵